Nektar Therapeutics Market Cap

Nektar Therapeutics has a market cap or net worth of 632.6 million as of December 31, 2025. Its market cap has increased by 335.60% in one year.

Market Cap

632.60M

Enterprise Value

556.06M

Revenue

46.57M

Ranking

n/a

PE Ratio

n/a

Stock Price

42.08

Market Cap Chart

Since May 3, 1994, Nektar Therapeutics's market cap has increased from 42.81M to 632.60M, an increase of 1,377.56%. That is a compound annual growth rate of 8.87%.

Market Cap History

Date	Market Cap	% Change
Dec 30, 2025	632.60M	361.67%
Dec 31, 2024	137.03M	61.93%
Dec 29, 2023	84.62M	-76.00%
Dec 30, 2022	352.54M	-80.85%
Dec 31, 2021	1.84B	-17.57%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	213.19B
GSK plc	73.15B
Haleon	33.22B
Smith & Nephew	10.43B
Convatec Group	4.74B
Hikma Pharmaceuticals	3.40B
Genus	1.73B
HUTCHMED (China)	1.71B

Market Cap Rankings